Rani Therapeutics Holdings (RANI) Return on Assets (2021 - 2026)

Rani Therapeutics Holdings' Return on Assets history runs 6 years deep, the most recent figure standing at 0.01% for Q1 2026.

• On a quarterly basis, Return on Assets rose 1.0% year-over-year to 0.01% in Q1 2026; TTM through Mar 2026 was 0.01%, a 1.0% increase from a year earlier, with the FY2025 full-year figure at 0.02%, down 1.0% from the prior year.
• Return on Assets advanced to 0.01% in Q1 2026 per RANI's latest filing, from 0.01% in the prior quarter.
• Across five years, Return on Assets topped out at 0.01% in Q1 2022 and bottomed at 0.04% in Q3 2025.
• The 5-year median for Return on Assets is 0.01% (2023), against an average of 0.01%.
• Across the five-year window, Return on Assets decreased 2 bps in 2025 and climbed 1 bps in 2026, its largest moves.
• Year by year, Return on Assets stood at 0.01% in 2022, then sank by 80 bps to 0.01% in 2023, then slumped by 46 bps to 0.02% in 2024, then gained by 16 bps to 0.01% in 2025, then surged by 41 bps to 0.01% in 2026.
• Per Business Quant, the three latest RANI Return on Assets figures stand at 0.01% (Q1 2026), 0.01% (Q4 2025), and 0.04% (Q3 2025).